05.11.2014 01:07:38
|
Genomic Health Q3 Loss Narrower Than Estimates, Revenue Misses; Stock Down 6%
(RTTNews) - Genomic Health Inc (GHDX) Tuesday reported third-quarter net loss of $6.3 million or $0.20 per share compared with a profit of $488 thousand or $0.02 per share last year.
Results for the 2014 quarter included non-cash charges of $5.7 million.
Revenues for the quarter were $69 million compared with $66 million in the prior year.
Analysts polled by Thomson Reuters estimated a loss of $0.22 per share on revenues of $71 million for the quarter. Analysts' estimates typically exclude special items.
Operating expenses for the quarter were $74.9 million compared with $65.5 million last year.
Genomic Health, based in Redwood City, California, provides actionable genomic information to personalize cancer treatment decisions.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Genomic Health IncShsmehr Nachrichten
Keine Nachrichten verfügbar. |